Aug 03, 09
|
| NEW STORY |
| 11:10 ET |
Human Genome Sciences Announces Closing of Public Offering
|
 |
Jul 28, 09
|
| 19:45 ET |
Human Genome Sciences Announces Pricing of Public Offering of Common Stock
|
|
Jul 27, 09
|
| 16:11 ET |
Human Genome Sciences Announces Proposed Public Offering of Common Stock
|
|
Jul 22, 09
|
| 16:05 ET |
Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments
|
|
| 07:00 ET |
Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government
|
|
Jul 20, 09
|
| 07:00 ET |
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
|
|
| 00:05 ET |
Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
|
|
| 00:01 ET |
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
|
|
Jul 09, 09
|
| 07:00 ET |
Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
|
|
Jul 01, 09
|
| 07:00 ET |
Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
|
|
Jun 19, 09
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
|
|
| 07:00 ET |
Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
|
|
Jun 11, 09
|
| 07:00 ET |
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
|
|
Jun 08, 09
|
| 12:53 ET |
FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight
|
|
May 21, 09
|
| 07:00 ET |
Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
|
|
May 07, 09
|
| 07:01 ET |
Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
|
|
Apr 29, 09
|
| 16:05 ET |
Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
|
|
Apr 25, 09
|
| 10:00 ET |
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
|
|
Apr 22, 09
|
| 16:00 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
|
|
Mar 27, 09
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Conference
|
|
Mar 25, 09
|
| 07:16 ET |
Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
|
|
Mar 13, 09
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Cowen Conference
|
|
Mar 09, 09
|
| 07:01 ET |
Human Genome Sciences to Sponsor Conference Call
|
|
| 07:00 ET |
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
|
|
Feb 26, 09
|
| 16:11 ET |
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
|
|
Feb 19, 09
|
| 08:00 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2008 Financial Results
|
|
Feb 17, 09
|
| 09:16 ET |
Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
|
|
Feb 02, 09
|
| 06:00 ET |
Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
|
|
Jan 12, 09
|
| 07:23 ET |
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
|
|
| 07:00 ET |
Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
|
|
Jan 09, 09
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
|
|
Dec 18, 08
|
| 10:09 ET |
FYI from Human Genome Sciences: GSK Initiates Darapladib Phase 3 Development Program
|
|
Dec 08, 08
|
| 07:01 ET |
Human Genome Sciences to Sponsor Conference Call
|
|
| 07:00 ET |
Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
|
|
Nov 26, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
|
|
Nov 17, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lazard Capital Conference
|
|
Nov 07, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
|
|
Nov 06, 08
|
| 16:05 ET |
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
|
|
Oct 30, 08
|
| 08:00 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
|
|
Oct 03, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
|
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
|
|
Sep 18, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
|
|
Sep 08, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
|
|
Sep 04, 08
|
| 07:00 ET |
Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
|
|
Sep 02, 08
|
| 16:05 ET |
Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
|
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
|
|
Aug 27, 08
|
| 07:00 ET |
Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
|
|
Aug 22, 08
|
| 07:00 ET |
Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
|
|
Jul 30, 08
|
| 16:16 ET |
Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
|
|
Jul 24, 08
|
| 07:00 ET |
Human Genome Sciences Appoints David P. Southwell to its Board of Directors
|
|
Jul 23, 08
|
| 16:05 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
|
|
Jun 12, 08
|
| 07:00 ET |
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
|
|
Jun 09, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference
|
|
May 30, 08
|
| 12:16 ET |
Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
|
|
May 28, 08
|
| 07:00 ET |
Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
|
|
May 21, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentations at Analyst & Investor Meeting
|
|
May 16, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Conference
|
|
May 15, 08
|
| 07:00 ET |
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
|
|
May 08, 08
|
| 07:00 ET |
Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of Directors
|
|
May 05, 08
|
| 16:01 ET |
Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
|
|
Apr 28, 08
|
| 16:05 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
|
|
Apr 22, 08
|
| 07:09 ET |
Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
|
|
Apr 16, 08
|
| 16:01 ET |
Human Genome Sciences to Sponsor Conference Call
|
|
| 16:00 ET |
Human Genome Sciences Advances Oncology Portfolio
|
|
Mar 14, 08
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lehman Brothers Conference
|
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Cowen Conference
|
|
Mar 03, 08
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
|
|
Feb 25, 08
|
| 16:00 ET |
Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
|
|
Feb 21, 08
|
| 10:30 ET |
Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
|
|
Feb 19, 08
|
| 16:00 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2007 Financial Results
|
|
Feb 07, 08
|
| 07:00 ET |
Human Genome Sciences and Xencor Announce Antibody Collaboration
|
|
Feb 04, 08
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
|
|
Jan 23, 08
|
| 07:01 ET |
Human Genome Sciences To Sponsor Conference Call
|
|
| 07:00 ET |
Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)
|
|
Jan 07, 08
|
| 07:00 ET |
Human Genome Sciences Announces 2008 Goals and Reports Substantial Progress Toward Commercialization at JPMorgan Healthcare Conference
|
|
Jan 04, 08
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
|
|
Dec 20, 07
|
| 07:02 ET |
Human Genome Sciences to Sponsor Conference Call
|
|
| 07:01 ET |
Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
|
|
| 07:00 ET |
Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
|
|
Dec 18, 07
|
| 07:00 ET |
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
|
|
Nov 26, 07
|
| 09:30 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
|
|
Nov 12, 07
|
| 07:12 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Biotech Conference
|
|
Nov 09, 07
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference
|
|
| 07:00 ET |
Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
|
|
Nov 05, 07
|
| 07:02 ET |
Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C
|
|
| 07:02 ET |
Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy
|
|
| 07:00 ET |
Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C
|
|
Nov 01, 07
|
| 07:01 ET |
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
|
|
| 07:00 ET |
Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial
|
|
Oct 24, 07
|
| 16:00 ET |
Human Genome Sciences To Sponsor Conference Call To Discuss Third Quarter 2007 Financial Results
|
|
| 07:00 ET |
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
|
|
Sep 20, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Investment Conference
|
|
Sep 14, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
|
|
Sep 07, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
|
|
Sep 04, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
|
|
Aug 31, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
|
|
Aug 28, 07
|
| 07:01 ET |
Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
|
|
| 07:00 ET |
Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
|
|
Aug 01, 07
|
| 07:00 ET |
Human Genome Sciences Announces Second Quarter 2007 Financial Results and Key Developments
|
|
Jul 25, 07
|
| 16:05 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2007 Financial Results
|
|
Jun 14, 07
|
| 07:00 ET |
Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B(R) Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
|
|
Jun 07, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference
|
|
| 07:00 ET |
Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon(R)
|
|
Jun 04, 07
|
| 16:00 ET |
Human Genome Sciences Invites Investors To Listen To Webcast of Presentation at Bear Stearns Conference
|
|
May 30, 07
|
| 07:00 ET |
Human Genome Sciences and GlaxoSmithKline Initiate Second Phase 3 Clinical Trial of LymphoStat-B(R) in Systemic Lupus Erythematosus
|
|
May 24, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bank of America Conference
|
|
May 18, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citigroup Conference
|
|
May 17, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
|
|
May 11, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bank of America Conference
|
|
May 09, 07
|
| 07:00 ET |
Human Genome Sciences Announces First Quarter 2007 Financial Results and Key Developments
|
|
May 03, 07
|
| 08:30 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2007 Financial Results
|
|
May 01, 07
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
|
|
Apr 27, 07
|
| 11:53 ET |
Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers
|
|
Apr 14, 07
|
| 10:00 ET |
Human Genome Sciences Reports Positive Interim Results of Phase 2b Trial of Albuferon(R)
|
|
Mar 16, 07
|
| 08:00 ET |
MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities
|
|
Mar 15, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lehman Brothers Conference
|
|
Mar 09, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citigroup Conference
|
|
Feb 27, 07
|
| 16:08 ET |
Human Genome Sciences Announces Financial Results for 2006 and Progress Toward Commercialization
|
|
| 16:06 ET |
Human Genome Sciences Initiates Phase 3 Clinical Trial of Albuferon(R) With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C Genotypes 2 and 3
|
|
| 16:05 ET |
Human Genome Sciences Announces Positive Interim Results of Phase 2b Trial of Albuferon(R) With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
|
|
Feb 21, 07
|
| 16:10 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2006 Financial Results
|
|
Feb 13, 07
|
| 07:12 ET |
Human Genome Sciences and GlaxoSmithKline Announce Initiation of Phase 3 Clinical Trial of LymphoStat-B(R) in Systemic Lupus Erythematosus
|
|
Feb 02, 07
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
|
|
Jan 26, 07
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Wachovia Conference
|
|
Jan 08, 07
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
|
|
| 07:00 ET |
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2007 Goals at JPMorgan Healthcare Conference
|
|
Dec 19, 06
|
| 07:00 ET |
Human Genome Sciences Initiates Phase 3 Clinical Trial of Albuferon(R) in Combination With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
|
|
Nov 27, 06
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
|
|
Nov 14, 06
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
|
|
| 07:00 ET |
Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus
|
|
Nov 08, 06
|
| 06:45 ET |
Human Genome Sciences Announces Financial Results for the Third Quarter of 2006
|
|
| 06:35 ET |
Human Genome Sciences Reports Interim Results of Phase 1b Clinical Trial of HGS-ETR1 With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
|
|
Nov 01, 06
|
| 08:00 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2006 Financial Results
|
|
Oct 31, 06
|
| 08:00 ET |
Human Genome Sciences Reports Positive Interim Results of Phase 2 Trials of Albuferon(TM) With Ribavirin in Patients With Chronic Hepatitis C
|
|
Oct 26, 06
|
| 07:00 ET |
Human Genome Sciences Announces Positive Special Protocol Assessment From FDA for Phase 3 Clinical Trials of LymphoStat-B(TM) In Systemic Lupus Erythematosus
|
|
Oct 19, 06
|
| 07:00 ET |
Human Genome Sciences Appoints Kevin Starr to Its Board of Directors
|
|
Oct 16, 06
|
| 07:00 ET |
Human Genome Sciences Reports Positive Interim Quality-of-Life Data From Phase 2B Trial of Albuferon(TM) with Ribavirin in Treatment-Naive Hepatitis C Patients
|
|
Oct 04, 06
|
| 07:01 ET |
Human Genome Sciences Reports Significant Progress and Outlines Its Next Steps on the Path to Commercialization
|
|
| 07:00 ET |
Human Genome Sciences Announces Phase 3 Clinical Development Program for Albuferon(TM) in Chronic Hepatitis C
|
|
Sep 29, 06
|
| 17:00 ET |
Human Genome Sciences Reports Positive Results of Phase 1 Clinical Trial of CCR5 mAb in Patients Infected with HIV-1
|
|
Sep 27, 06
|
| 16:10 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentations at Analyst & Investor Meeting
|
|
Sep 21, 06
|
| 08:30 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Securities Conference
|
|
Sep 07, 06
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
|
|
Aug 30, 06
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
|
|
Aug 29, 06
|
| 16:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Investment Conference
|
|
Aug 09, 06
|
| 06:31 ET |
Human Genome Sciences Announces Financial Results for the Second Quarter of 2006
|
|
| 06:30 ET |
Human Genome Sciences Announces Phase 3 Clinical Development Program for LymphoStat-B(TM) in Systemic Lupus Erythematosus
|
|
Aug 03, 06
|
| 07:00 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2006 Financial Results
|
|
Jul 20, 06
|
| 07:00 ET |
Human Genome Sciences Initiates Randomized Phase 2 Clinical Trial of HGS-ETR1 in Combination With Bortezomib
|
|
Jul 10, 06
|
| 10:18 ET |
Human Genome Sciences Names Timothy C. Barabe Senior Vice President and Chief Financial Officer
|
|
Jun 22, 06
|
| 07:00 ET |
Human Genome Sciences Announces Full Presentation of Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus
|
|
Jun 20, 06
|
| 08:31 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss U.S. Government Agreement to Purchase ABthrax(TM) for the Strategic National Stockpile
|
|
| 08:30 ET |
U.S. Government Agrees to Purchase ABthrax(TM) From Human Genome Sciences for the Strategic National Stockpile
|
|
Jun 12, 06
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Pacific Growth Conference
|
|
| 07:01 ET |
Human Genome Sciences Completes Transaction Establishing CoGenesys as an Independent Company
|
|
| 07:00 ET |
CoGenesys Raises $55 Million in Series A Financing
|
|
Jun 09, 06
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference
|
|
Jun 06, 06
|
| 01:16 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Collaboration With Novartis for Development and Commercialization of Albuferon(TM)
|
|
| 01:15 ET |
Human Genome Sciences Announces Collaboration with Novartis for Development and Commercialization of Albuferon(TM)
|
|
Jun 02, 06
|
| 13:40 ET |
Human Genome Sciences Names Margery B. Fischbein Vice President, Business Development & Strategic Planning
|
|
May 12, 06
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bank of America Conference
|
|
May 10, 06
|
| 07:00 ET |
Human Genome Sciences Announces Results for First Quarter of 2006
|
|
May 05, 06
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
|
|
May 02, 06
|
| 17:00 ET |
Human Genome Sciences Facilities Transactions to Generate $380 Million in Additional Cash Available for Operations
|
|
May 01, 06
|
| 07:02 ET |
Human Genome Sciences Presents Interim Results of Phase 2 Trial of Albuferon(TM) with Ribavirin in Patients with Chronic Hepatitis C Who Failed to Respond to Previous Therapy
|
|
| 07:00 ET |
Human Genome Sciences Presents Interim Results of Phase 2b Trial of Albuferon(TM) With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
|
|
Mar 14, 06
|
| 08:06 ET |
Human Genome Sciences Reports Positive Interim Results of Phase 2 Trial of Albuferon(TM) In Combination With Ribavirin In Treatment-Experienced Patients With Chronic Hepatitis C
|
|
| 08:05 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Interim Results of Two Phase 2 Trials of Albuferon(TM)
|
|
| 08:02 ET |
Human Genome Sciences Announces Positive Interim Results of Phase 2b Clinical Trial Of Albuferon(TM) in Combination With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
|
|
Mar 10, 06
|
| 08:31 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citigroup Conference
|
|
Mar 06, 06
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
|
|
Mar 03, 06
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lehman Brothers Conference
|
|
Feb 22, 06
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citigroup Conference
|
|
Feb 10, 06
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bio Investor Conference
|
|
Feb 09, 06
|
| 09:38 ET |
Human Genome Sciences Reports Financial Results for Full Year and Fourth Quarter 2005
|
|
Feb 03, 06
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
|
|
Jan 10, 06
|
| 07:10 ET |
Human Genome Sciences Reports on Progress Toward Commercialization and Announces 2006 Goals at JPMorgan Healthcare Conference
|
|
| 07:01 ET |
Human Genome Sciences Licenses Worldwide Intellectual Property Rights for Target Antigen to PDL BioPharma
|
|
| 07:01 ET |
Human Genome Sciences Receives Milestone Payment From GlaxoSmithKline for Filing of GSK716155 IND Application to Begin Phase 1 Trials in the Treatment of Diabetes
|
|
Jan 09, 06
|
| 17:02 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
|
|
| 07:01 ET |
Human Genome Sciences Announces License Agreement With Amgen
|
|
Jan 06, 06
|
| 16:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
|
|
Dec 13, 05
|
| 16:06 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Decision to Spin Off CoGenesys Division as an Independent Company
|
|
| 16:05 ET |
Human Genome Sciences Announces Decision to Spin Off CoGenesys Division as an Independent Company
|
|
Dec 12, 05
|
| 13:33 ET |
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of HGS-ETR1 In Patients With Advanced Non-Hodgkin's Lymphoma
|
|
Dec 01, 05
|
| 08:30 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at First Albany Conference
|
|
| 07:00 ET |
Human Genome Sciences Appoints Tuan Ha-Ngoc to its Board of Directors
|
|
Nov 17, 05
|
| 12:31 ET |
Human Genome Sciences Reports Results of Phase 1 Clinical Trials of HGS-ETR2 in Patients with Advanced Solid Tumors
|
|
| 12:30 ET |
Human Genome Sciences Reports Interim Results of Phase 1b Clinical Trials of HGS-ETR1 in Combination With Chemotherapy in Patients With Advanced Solid Tumors
|
|
| 07:02 ET |
Human Genome Sciences Reports Phase 2 Results for LymphoStat-B(TM) (Belimumab) In Patients With Rheumatoid Arthritis
|
|
Nov 15, 05
|
| 12:01 ET |
Human Genome Sciences Reports Interim Results of Phase 2 Clinical Trial of Albuferon(TM) in Combination With Ribavirin in Treatment-Experienced Hepatitis C Patients
|
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Credit Suisse First Boston Conference
|
|
Nov 08, 05
|
| 16:07 ET |
Human Genome Sciences Calls for Redemption All of Its Remaining Outstanding Subordinated Notes Due 2007
|
|
Nov 03, 05
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at CIBC World Markets Conference
|
|
Nov 01, 05
|
| 07:10 ET |
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of HGS-ETR1 In Patients With Advanced Colorectal Cancer
|
|
Oct 25, 05
|
| 07:03 ET |
Human Genome Sciences Announces Financial Results for the Third Quarter of 2005
|
|
| 06:55 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2b Clinical Trial of Albuferon(TM) in Combination With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
|
|
Oct 12, 05
|
| 07:00 ET |
Human Genome Sciences Appoints Robert C. Young, M.D., to Its Board of Directors
|
|
Oct 05, 05
|
| 07:02 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Phase 2 Clinical Results of LymphoStat-B(TM) in Systemic Lupus Erythematous Patients
|
|
| 07:01 ET |
Human Genome Sciences Reports Results of a Phase 2 Clinical Trial of LymphoStat-B(TM) in Patients With Systemic Lupus Erythematosus
|
|
Oct 03, 05
|
| 07:01 ET |
Human Genome Sciences Awarded Two-Phase Contract to Supply ABthrax(TM) for the Treatment of Inhalational Anthrax Disease to the U.S. Government
|
|
Sep 22, 05
|
| 17:05 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
|
|
Sep 15, 05
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Banc of America Conference
|
|
Sep 08, 05
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
|
|
Sep 06, 05
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury Conference
|
|
Sep 02, 05
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Discussion at Thomas Weisel Partners Conference
|
|
Aug 18, 05
|
| 07:00 ET |
GlaxoSmithKline Exercises Option to Human Genome Sciences' Trail Receptor Antibody
|
|
Aug 09, 05
|
| 12:37 ET |
Human Genome Sciences Announces Completion of Offering
|
|
Aug 04, 05
|
| 11:21 ET |
Human Genome Sciences Announces Pricing of $230 Million Private Placement of Convertible Subordinated Notes
|
|
Aug 03, 05
|
| 16:06 ET |
Human Genome Sciences Announces Proposed Private Offering of Convertible Subordinated Notes
|
|
Aug 01, 05
|
| 07:04 ET |
Human Genome Sciences Receives Milestone Payments from GlaxoSmithKline for GSK716155 Progress
|
|
Jul 25, 05
|
| 16:15 ET |
Human Genome Sciences Announces Financial Results for the Second Quarter of 2005
|
|
Jul 22, 05
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Banc of America Conference
|
|
Jul 18, 05
|
| 16:03 ET |
Human Genome Sciences Publishes Results of Phase 1 Clinical Trial of ABthrax(TM) for Use in Prevention and Treatment of Anthrax Infection
|
|
Jul 14, 05
|
| 07:04 ET |
Human Genome Sciences Names Barry A. Labinger Executive Vice President and Chief Commercial Officer
|
|
Jul 07, 05
|
| 07:00 ET |
GlaxoSmithKline Exercises Option to LymphoStat-B(TM)
|
|
Jul 05, 05
|
| 07:21 ET |
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of HGS-ETR1 In Patients With Non-Small Cell Lung Cancer
|
|
Jun 13, 05
|
| 07:15 ET |
Human Genome Sciences Reports Interim Results of Phase 2 Clinical Trial of HGS-ETR1 in Patients with Advanced Non-Hodgkin's Lymphoma
|
|
Jun 10, 05
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference
|
|
Jun 01, 05
|
| 07:17 ET |
Human Genome Sciences Initiates Phase 2b Clinical Trial of Albuferon(TM) in Combination With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
|
|
May 26, 05
|
| 07:54 ET |
Human Genome Sciences Reports on Progress Toward Commercialization
|
|
May 19, 05
|
| 08:30 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Analyst & Investor Meeting
|
|
May 17, 05
|
| 07:17 ET |
Human Genome Sciences Reports Results of Preclinical Study Comparing Anti-Viral Activity of Albuferon(TM) And Three Other Forms of Interferon Alpha Used to Treat Hepatitis C
|
|
| 07:15 ET |
Human Genome Sciences Reports Results Of Phase 1 Clinical Trials of HGS-ETR2 and HGS-ETR1 In Patients With Advanced Solid Tumors
|
|
May 12, 05
|
| 16:10 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Banc of America Conference
|
|
May 09, 05
|
| 17:14 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Growth Stock Conference
|
|
Apr 25, 05
|
| 16:18 ET |
Human Genome Sciences Announces Financial Results for First Quarter of 2005
|
|
Apr 18, 05
|
| 07:08 ET |
Human Genome Sciences Reports Results of Phase 1 Clinical Trial of HGS-ETR1 in Patients With Advanced Solid Tumors
|
|
Apr 14, 05
|
| 10:45 ET |
Human Genome Sciences Reports Positive Results of Phase 2 Clinical Trial of Albuferon(TM) in Treatment-Naive Patients With Chronic Hepatitis C
|
|
Apr 06, 05
|
| 06:30 ET |
Human Genome Sciences Reports Results of a Phase 2 Clinical Trial of LymphoStat-B(TM) in Patients with Rheumatoid Arthritis
|
|
Mar 30, 05
|
| 07:15 ET |
Human Genome Sciences Begins Dosing of Patients in a Phase 1 Clinical Trial of CCR5 mAb in Patients Infected With HIV-1
|
|
Mar 28, 05
|
| 16:10 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lehman Brothers' Conference
|
|
Mar 11, 05
|
| 16:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at SG Cowen Conference
|
|
Mar 03, 05
|
| 07:15 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2 Clinical Trial of HGS-ETR1 for the Treatment of Non-Hodgkin's Lymphoma
|
|
Feb 25, 05
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcasts From Two Securities Conferences
|
|
Feb 23, 05
|
| 07:15 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2 Clinical Trial of HGS-ETR1 for the Treatment of Colorectal Cancer
|
|
Feb 16, 05
|
| 07:15 ET |
Human Genome Sciences Completes Enrollment in a Phase 2 Clinical Trial of Albuferon(TM) in Treatment-Naive Patients with Chronic Hepatitis C
|
|
Feb 07, 05
|
| 16:15 ET |
Human Genome Sciences Reports Financial Results for Full Year and Fourth Quarter 2004
|
|
| 07:55 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
|
|
Jan 20, 05
|
| 16:05 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Health Care Conference
|
|
Jan 10, 05
|
| 07:08 ET |
Human Genome Sciences Reports On Progress Of Clinical Trials And Announces Goals for 2005 at JPMorgan Healthcare Conference
|
|
| 07:01 ET |
Human Genome Sciences Receives FDA Clearance to Initiate Clinical Development of a New Compound for the Treatment of HIV/AIDS
|
|
Jan 07, 05
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Healthcare Conference
|
|
Dec 22, 04
|
| 16:41 ET |
Human Genome Sciences Announces Agreement to Exit Facility at 9800 Medical Center Drive
|
|
Nov 30, 04
|
| 07:17 ET |
Human Genome Sciences Initiates Phase 2 Clinical Trial of Albuferon(TM) In Combination With Ribavirin in Treatment-Experienced Hepatitis C Patients
|
|
| 07:16 ET |
Human Genome Sciences Completes Patient Enrollment in A Phase 2 Clinical Trial of HGS-ETR1 for the Treatment of Non-Small Cell Lung Cancer
|
|
Nov 22, 04
|
| 07:15 ET |
H. Thomas Watkins Appointed Chief Executive Officer of Human Genome Sciences
|
|
Nov 08, 04
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at CIBC World Markets Investment Conference
|
|
Nov 02, 04
|
| 12:43 ET |
Human Genome Sciences Characterizes Panel of Novel Human Monoclonal Antibodies That Specifically Antagonize the CCR5 Receptor and Block HIV-1 Entry
|
|
| 12:42 ET |
Human Genome Sciences Reports Results of Preclinical Studies of HGS-TR2J (TRAIL-R2 mAb) and TRAIL-R2 Protein Expression
|
|
| 12:41 ET |
Human Genome Sciences Reports Positive Results of Phase 1/2 Clinical Trial of Albuferon(TM) in Chronic Hepatitis C
|
|
Oct 26, 04
|
| 07:17 ET |
Human Genome Sciences Announces Third Quarter 2004 Financial Results
|
|
| 07:15 ET |
Human Genome Sciences Announces Agreement With GlaxoSmithKline for Development and Commercialization of Novel Drug to Treat Diabetes
|
|
Oct 19, 04
|
| 12:48 ET |
Human Genome Sciences Announces Completion of Repurchase of Convertible Subordinated Notes
|
|
Oct 13, 04
|
| 08:03 ET |
Human Genome Sciences Begins Dosing of Patients in a Phase 2 Clinical Trial of HGS-ETR1 in Non-Hodgkin's Lymphoma
|
|
| 08:00 ET |
Human Genome Sciences Initiates a Phase 2 Clinical Trial of HGS-ETR1 in Patients With Colorectal Cancer
|
|
Oct 04, 04
|
| 12:21 ET |
Human Genome Sciences Announces Completion of Offering
|
|
Oct 01, 04
|
| 08:15 ET |
Human Genome Sciences Reports Results of Preclinical Studies of TRAIL-R1 and TRAIL-R2 Agonistic Human Monoclonal Antibodies at EORTC-NCI-AACR Symposium
|
|
Sep 29, 04
|
| 09:40 ET |
Human Genome Sciences Reports Results of Ongoing Phase 1 Clinical Trials of HGS-ETR1 in Patients With Advanced Cancers
|
|
| 08:31 ET |
Human Genome Sciences Reports Initial Results of Phase 1 Clinical Trials of HGS-ETR2 (TRAIL-R2 MAB) in Patients With Advanced Cancers
|
|
| 08:02 ET |
Human Genome Sciences Announces Pricing of $250 Million Private Placement of Convertible Subordinated Notes
|
|
Sep 27, 04
|
| 16:01 ET |
Human Genome Sciences Announces Proposed Private Offering of Convertible Subordinated Notes
|
|
| 11:03 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
|
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
|
|
Sep 20, 04
|
| 08:15 ET |
Argeris (Jerry) N. Karabelas, Ph.D., to Become Chairman of Human Genome Sciences Board; Craig A. Rosen, Ph.D., Named President and Chief Operating Officer
|
|
Sep 15, 04
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Banc of America Conference
|
|
Sep 08, 04
|
| 08:15 ET |
Human Genome Sciences Advances Anti-Cancer Drug to Phase 2 Clinical Development
|
|
Sep 07, 04
|
| 16:10 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury/Thomson Financial Conference
|
|
Aug 24, 04
|
| 08:15 ET |
Human Genome Sciences Initiates Clinical Development of New Drug for the Treatment of Cancer
|
|
Jul 30, 04
|
| 07:45 ET |
Human Genome Sciences Reports Second Quarter 2004 Financial Results
|
|
Jul 29, 04
|
| 08:20 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2 Clinical Trial of LymphoStat-B(Tm) for the Treatment of Rheumatoid Arthritis
|
|
| 08:15 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2 Clinical Trial of LymphoStat-B(TM) for the Treatment of Systemic Lupus Erythematosus
|
|
| 03:20 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2 Clinical Trial of LymphoStat-B(TM) for the Treatment of Rheumatoid Arthritis
|
|
| 03:15 ET |
Human Genome Sciences Completes Patient Enrollment in a Phase 2 Clinical Trial of LymphoStat-B(TM) for the Treatment of Systemic Lupus Erythematosus
|
|
Jul 27, 04
|
| 16:05 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Banc of America Conference
|
|
Jun 07, 04
|
| 09:05 ET |
Human Genome Sciences Reports Results of Phase 1 Clinical Trials of HGS-ETR1 (TRAIL-R1 MAB) in Patients with Advanced Cancers
|
|
Jun 03, 04
|
| 16:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference
|
|
May 26, 04
|
| 08:20 ET |
Human Genome Sciences Initiates Phase 2 Clinical Trial of Albuferon(TM) for the Treatment of Chronic Hepatitis C
|
|
Apr 30, 04
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
|
|
Apr 28, 04
|
| 16:11 ET |
Human Genome Sciences Reports Financial Results for First Quarter of 2004
|
|
Apr 23, 04
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at CIBC World Markets Conference
|
|
Mar 31, 04
|
| 08:06 ET |
Human Genome Sciences Announces License Agreement With DakoCytomation for Development of Pharmacogenomic Diagnostic Assays
|
|
Mar 30, 04
|
| 08:05 ET |
Human Genome Sciences Receives Milestone Payment From GlaxoSmithKline for Initiation of Clinical Trials of Genomics-Derived Drug for Cardiovascular Disease
|
|
Mar 25, 04
|
| 08:05 ET |
Human Genome Sciences to Sharpen Focus - Announces Plans to Concentrate on Drugs of Highest Potential
|
|
| 08:05 ET |
William Haseltine Plans to Retire as Chairman and Chief Executive Officer of Human Genome Sciences
|
|
Mar 09, 04
|
| 08:01 ET |
Human Genome Sciences Reports Results of Phase 1 Clinical Trial of ABthrax(TM) for Use in Prevention and Treatment of Anthrax Infection
|
|
Mar 05, 04
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentations at SG Cowen Conference
|
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at JMP Securities Conference
|
|
Mar 04, 04
|
| 08:33 ET |
Human Genome Sciences Announces Selection of Lymphostat-B(TM) for Participation in FDA's Continuous Marketing Application Pilot 2 Program
|
|
Mar 03, 04
|
| 08:15 ET |
Human Genome Sciences Appoints New Members to Its Board of Directors
|
|
Feb 27, 04
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Lehman Brothers Conference
|
|
Feb 20, 04
|
| 08:18 ET |
Human Genome Sciences to Participate in BIO CEO + Investor 2004 Conference
|
|
Feb 17, 04
|
| 17:10 ET |
Human Genome Sciences Confirms Stock Sale and Transfer By Chairman and CEO
|
|
| 08:15 ET |
Human Genome Sciences Awarded 'Workplace Excellence' Seal of Approval By Maryland Work-Life Alliance
|
|
Feb 10, 04
|
| 08:15 ET |
Human Genome Sciences Reports Financial Results For Full Year and Fourth Quarter 2003
|
|
Feb 05, 04
|
| 16:05 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Full Year and Fourth Quarter 2003 Financial Results
|
|
Feb 02, 04
|
| 17:00 ET |
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of Repifermin in Patients With Cancer Therapy-Induced Mucositis
|
|
Jan 23, 04
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Piper Jaffray Conference
|
|
Jan 12, 04
|
| 07:45 ET |
Human Genome Sciences Updates Progress of Six Drugs in Clinical Trials at JPMorgan Conference
|
|
Jan 09, 04
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at JPMorgan Conference
|
|
Jan 08, 04
|
| 07:45 ET |
Human Genome Sciences Initiates Phase 2 Clinical Trial Of LymphoStat-B(TM) for the Treatment Of Rheumatoid Arthritis
|
|
Dec 18, 03
|
| 13:32 ET |
Human Genome Sciences Announces License Agreement With Pfizer
|
|
Dec 09, 03
|
| 12:30 ET |
Human Genome Sciences Reports Interim Results of Phase 1 Clinical Trials of LymphoRad(TM)(131) at 45th Annual Meeting of the American Society of Hematology
|
|
Dec 08, 03
|
| 16:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Harris Nesbitt Gerard Conference
|
|
Dec 05, 03
|
| 08:59 ET |
Genomics-Derived Drug for Cardiovascular Disease to Advance To Phase 3 Clinical Trials
|
|
Nov 10, 03
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Credit Suisse First Boston Conference
|
|
Nov 06, 03
|
| 08:01 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at CIBC World Markets Conference
|
|
Oct 28, 03
|
| 08:25 ET |
Human Genome Sciences Reports Results of Phase 1 Clinical Trial of Lymphostat-B(TM) in Patients with Systemic Lupus Erythematosus
|
|
| 08:18 ET |
Human Genome Sciences Reports Third Quarter 2003 Financial Results
|
|
| 08:05 ET |
Human Genome Sciences Reports Interim Results of Phase 1/2 Clinical Trial of Albuferon(TM) in Patients Infected With Hepatitis C Virus
|
|
Oct 23, 03
|
| 16:47 ET |
Human Genome Sciences to Host Conference Call to Discuss Third Quarter 2003 Financial Results
|
|
| 16:05 ET |
Human Genome Sciences to Host Conference Call to Discuss Second Quarter 2003 Financial Results
|
|
Sep 25, 03
|
| 16:42 ET |
Human Genome Sciences Initiates Phase 2 Clinical Trial of LymphoStat-B(TM) for the Treatment of Systemic Lupus Erythematosus
|
|
| 16:42 ET |
Human Genome Sciences Reports Results of Clinical Trial of Repifermin in Patients with Chronic Venous Ulcers
|
|
Sep 18, 03
|
| 16:15 ET |
Human Genome Sciences Invites Investors to Listen To Webcast of Presentation at UBS Warburg Conference
|
|
Sep 17, 03
|
| 16:47 ET |
Human Genome Sciences Appoints New Members to its Board of Directors
|
|
Sep 15, 03
|
| 07:45 ET |
Human Genome Sciences Describes Activity of ABthrax(TM) at 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
|
|
Sep 04, 03
|
| 10:58 ET |
Human Genome Sciences Names Perry Karsen Senior Vice President, Business Development
|
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Bear Stearns Conference
|
|
Sep 02, 03
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen To Webcast of Presentation at BioCentury And Thomson Financial/Carson Conference
|
|
Aug 19, 03
|
| 08:31 ET |
Human Genome Sciences Receives Fast Track Product Designation For ABthrax for Prevention and Treatment of Anthrax Infections
|
|
Aug 07, 03
|
| 08:15 ET |
Human Genome Sciences Announces License Agreement With Genentech
|
|
Jul 29, 03
|
| 08:15 ET |
Human Genome Sciences Reports Second Quarter 2003 Financial Results
|
|
Jul 11, 03
|
| 08:30 ET |
Human Genome Sciences Initiates Clinical Development of Trail Receptor-2 Antibody for Treatment of Cancer
|
|
Jul 03, 03
|
| 08:15 ET |
Human Genome Sciences Restructures Real Estate Financings in Accordance with New FASB Guidance
|
|
Jun 25, 03
|
| 02:10 ET |
Human Genome Sciences Receives FDA Clearance to Initiate Human Trial of Novel Drug to Prevent and Treat Anthrax Infections
|
|
| 02:10 ET |
Human Genome Sciences Updates Progress of Clinical Programs at BIO 2003
|
|
Jun 20, 03
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at BIO 2003 Conference
|
|
Jun 06, 03
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Goldman Sachs Conference
|
|
Jun 02, 03
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Needham & Company Conference
|
|
May 30, 03
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at JMP Securities Conference
|
|
May 12, 03
|
| 07:45 ET |
Human Genome Sciences Provides Update of Company Progress
|
|
| 07:32 ET |
Human Genome Sciences Acquires License from Abgenix For Human Monoclonal Antibody to Key HIV/AIDS Receptor
|
|
May 09, 03
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Robert W. Baird Conference
|
|
May 05, 03
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentations at Annual Analyst & Investor Meeting
|
|
Apr 30, 03
|
| 08:17 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Morgan Stanley Conference
|
|
Apr 28, 03
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at CIBC World Markets Conference
|
|
Apr 25, 03
|
| 08:15 ET |
Human Genome Sciences Invites Investors to Listen to Webcasts Of Presentations at NASDAQ Life Sciences Forum
|
|
Apr 24, 03
|
| 07:45 ET |
Human Genome Sciences Reports Financial Results for First Quarter of 2003
|
|
Apr 22, 03
|
| 08:15 ET |
Human Genome Sciences to Host Conference Call to Discuss First Quarter 2003 Financial Results
|
|
Apr 21, 03
|
| 07:45 ET |
Results of Phase 1 Clinical Trial Demonstrate That LymphoStat-B(TM) Is Safe and Biologically Active in Patients with Systemic Lupus Erythematosus
|
|
Apr 02, 03
|
| 07:30 ET |
Results of Phase 2 Repifermin Clinical Trial Demonstrate Safety and Efficacy in Patients With Cancer Therapy-Induced Mucositis
|
|
Mar 21, 03
|
| 16:10 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Banc of America Health Care Conference
|
|
Mar 18, 03
|
| 03:00 ET |
Human Genome Sciences Develops New Means To Prevent and Treat Anthrax Infections
|
|
Mar 14, 03
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentations at SG Cowen Health Care Conference
|
|
Mar 03, 03
|
| 08:25 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Wachovia Securities Conference
|
|
Feb 28, 03
|
| 08:25 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Lehman Brothers Global Healthcare Conference
|
|
Feb 27, 03
|
| 11:19 ET |
Human Genome Sciences Receives Milestone Payment From GlaxoSmithKline for Initiation of Clinical Trials of Second Genomics-Derived Drug for Cardiovascular Disease
|
|
Feb 24, 03
|
| 08:20 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO's CEO & Investor Conference
|
|
Feb 14, 03
|
| 08:20 ET |
Human Genome Sciences Reports Financial Results For Full Year and Fourth Quarter 2002
|
|
Feb 13, 03
|
| 15:06 ET |
Human Genome Sciences Designated 'Excellent Place To Work' by Maryland Work-Life Alliance
|
|
Feb 12, 03
|
| 08:15 ET |
Human Genome Sciences to Sponsor Conference Call to Discuss Full Year and Fourth Quarter 2002 Financial Results
|
|
Jan 23, 03
|
| 04:00 ET |
Human Genome Sciences Establishes New Subsidiary in Europe
|
|
Jan 06, 03
|
| 07:45 ET |
Human Genome Sciences Reports Progress in Clinical Trials of Five Drugs at JP Morgan H&Q Conference
|
|
Jan 02, 03
|
| 08:00 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at JPMorgan H&Q Healthcare Conference
|
|
Dec 03, 02
|
| 07:45 ET |
Human Genome Sciences Announces Joint Development Of Antibody for the Treatment of Cancer With Kirin
|
|
Nov 11, 02
|
| 07:45 ET |
Human Genome Sciences Reports Results of Preclinical Studies of Albuleukin(TM) and Trail-R1 and Trail-R2 Agonistic Human Monoclonal Antibodies at the Society for Biological Therapy
|
|
Nov 04, 02
|
| 07:30 ET |
Interim Results of Phase 1 Albuferon(TM)-Alpha Clinical Trial Demonstrate Safety, Prolonged Half-Life, and Biological Activity in Patients Infected with Hepatitis C Virus
|
|
Nov 01, 02
|
| 16:05 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at CIBC World Markets Conference
|
|
Oct 29, 02
|
| 08:15 ET |
Human Genome Sciences Announces Third Quarter 2002 Financial Results
|
|
Oct 24, 02
|
| 16:05 ET |
Human Genome Sciences Invites Investors to Listen To Webcast of Presentation at Salomon Smith Barney Conference
|
|
Oct 23, 02
|
| 16:05 ET |
Human Genome Sciences Announces Conference Call to Discuss Third Quarter 2002 Financial Results
|
|
Oct 08, 02
|
| 08:01 ET |
Results of Phase 1 Albutropin(TM) Trial Demonstrate Safety, Prolonged Half-Life, and Biological Activity
|
|
Oct 02, 02
|
| 16:15 ET |
Human Genome Sciences Invites Investors to Listen To Webcast of Presentation at UBS Warburg Conference
|
|
Sep 17, 02
|
| 16:30 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Banc of America Investment Conference
|
|
Sep 13, 02
|
| 09:34 ET |
Human Genome Sciences Will Hold Approximately Fifteen Percent Equity Interest In Autus Genetics Corp.
|
|
Aug 21, 02
|
| 08:05 ET |
Human Genome Sciences Names Daniel Gold, Ph.D., Senior Vice President, Process Development
|
|
Aug 14, 02
|
| 08:08 ET |
Takeda Exercises Option to Develop Novel Human Genome Sciences Antibody Drug in Japan
|
|
Jul 25, 02
|
| 16:10 ET |
Human Genome Sciences Announces Second Quarter 2002 Financial Results
|
|
Jul 24, 02
|
| 08:37 ET |
Human Genome Sciences Licenses Two Human Antibody Targets To Schering-Plough for Drug Development
|
|
Jul 16, 02
|
| 08:01 ET |
Human Genome Sciences Receives a Milestone Payment for Initiation of Clinical Trials of a Genomics-Derived Drug for Osteoporosis by GlaxoSmithKline
|
|
Jul 15, 02
|
| 08:00 ET |
Human Genome Sciences Names Roberto Cetrullo Vice President, Business Development
|
|
Jun 07, 02
|
| 16:46 ET |
Human Genome Sciences Invites Investors to Listen to Webcast Of Presentation at Goldman, Sachs Investment Conference
|
|
| 16:45 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation At BIO 2002 Conference
|
|
Jun 05, 02
|
| 08:01 ET |
Human Genome Sciences Names Gilles Gallant, Ph.D., Vice President, Oncology
|
|
May 30, 02
|
| 16:06 ET |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation At Needham Investment Conference
|
|
May 20, 02
|
| 13:00 ET |
Human Genome Sciences Describes Activity of New Cancer Drug At American Society of Clinical Oncology Meeting
|
|
| 02:00 ET |
Human Genome Sciences and Cambridge Antibody Technology Commit to Exclusive Development of Antibody to Trail Receptor-2
|
|
May 14, 02
|
| 08:01 ET |
Human Genome Sciences Announces Clearance of Investigational New Drug Application for LymphoRad(131), a New Anticancer Drug for the Treatment of B-Cell Tumors
|
|
Apr 30, 02
|
| 14:31 ET |
Human Genome Sciences Provides Update of Company Progress
|
|
| 08:02 ET |
Human Genome Sciences Initiates Clinical Development of a Novel Anticancer Drug
|
|
Apr 25, 02
|
| 16:20 ET |
Human Genome Sciences Announces Webcast of Presentation At Investment Conference
|
|
| 16:15 ET |
Human Genome Sciences Announces Webcast of Presentations At Annual Analyst & Investor Meeting
|
|
Apr 16, 02
|
| 08:15 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Apr 15, 02
|
| 08:10 ET |
Human Genome Sciences Appoints Argeris (Jerry) N. Karabelas to Board of Directors
|
|
| 08:06 ET |
Human Genome Sciences Announces Development Plans for Drugs To Treat Chemotherapy-Induced Neutropenia
|
|
| 08:05 ET |
Human Genome Sciences Announces First Quarter 2002 Financial Results
|
|
Apr 11, 02
|
| 16:20 ET |
Human Genome Sciences Announces Conference Call To Discuss First Quarter 2002 Results
|
|
Apr 10, 02
|
| 08:15 ET |
Human Genome Sciences Presentations at the American Association for Cancer Research 93rd Annual Meeting
|
|
Apr 03, 02
|
| 16:34 ET |
Human Genome Sciences Announces Webcast Of Investment Conference Presentation
|
|
Feb 25, 02
|
| 16:30 ET |
Human Genome Sciences Announces Investment Conference Presentation
|
|
Feb 19, 02
|
| 17:35 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Feb 14, 02
|
| 08:15 ET |
Human Genome Sciences Reports Financial Results for Full Year And Fourth Quarter 2001
|
|
Feb 11, 02
|
| 08:42 ET |
Human Genome Sciences Announces Conference Call To Discuss 2001 Financial Results
|
|
Feb 04, 02
|
| 08:01 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Jan 29, 02
|
| 08:31 ET |
Human Genome Sciences Phase 2A Clinical Trial Results for Repifermin In Chronic Venous Ulcers Published in Leading Wound Care Journal
|
|
Jan 23, 02
|
| 08:31 ET |
Human Genome Sciences Files Investigational New Drug Application for Lymphorad(131)
|
|
Jan 08, 02
|
| 07:00 ET |
Cambridge Antibody Technology and Human Genome Sciences Announce Second Drug Partnership
|
|
Jan 07, 02
|
| 07:30 ET |
Human Genome Sciences Initiates Trial of Albuleukin(TM), A Recombinant Human Protein for Treating Solid Tumor Cancers
|
|
Jan 03, 02
|
| 08:20 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Dec 14, 01
|
| 08:20 ET |
Human Genome Sciences Completes Real Estate Financings
|
|
Dec 09, 01
|
| 10:15 ET |
Human Genome Sciences Presents Data at American Society of Hematology Meeting
|
|
Dec 07, 01
|
| 14:00 ET |
Results of Two Phase 2a Clinical Trials Show Excellent Safety Profile for Repifermin
|
|
Dec 06, 01
|
| 08:20 ET |
Human Genome Sciences to Sponsor Conference Call
|
|
Nov 26, 01
|
| 15:02 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Nov 14, 01
|
| 15:25 ET |
Human Genome Sciences Data Support Potential of LymphoStat-B As Treatment for Autoimmune Diseases
|
|
Nov 05, 01
|
| 16:38 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Nov 01, 01
|
| 09:01 ET |
Human Genome Sciences Initiates Trial of a New Drug for Systemic Lupus Erythematosus and Other Autoimmune Diseases
|
|
Oct 31, 01
|
| 09:05 ET |
Human Genome Sciences Will Sponsor Conference Call
|
|
Oct 29, 01
|
| 11:59 ET |
Human Genome Sciences Completes Enrollment in Phase 2 Trial Of Repifermin as a Treatment for Ulcerative Colitis
|
|
Oct 25, 01
|
| 17:30 ET |
Human Genome Sciences Announces Webcast Of Investment Conference Presentation
|
|
| 16:05 ET |
Human Genome Sciences Reports Financial Results for Third Quarter of 2001
|
|
Oct 22, 01
|
| 14:18 ET |
Scientific American Article Describes New Golden Age of Antiviral Drugs and Vaccines
|
|
| 12:30 ET |
Stemron Corporation Appoints Arthur M. Mandell President and Chief Executive Officer
|
|
Oct 17, 01
|
| 13:00 ET |
Human Genome Sciences Breaks Ground for a Large Scale Manufacturing Plant
|
|
Oct 05, 01
|
| 16:14 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
Sep 24, 01
|
| 17:15 ET |
Human Genome Sciences Announces Webcast of Investment Conference Presentation
|
|
| 08:15 ET |
Human Genome Sciences Completes Phase 2 Trial Enrollment For Repifermin as a Treatment for Mucositis
|
|
Sep 20, 01
|
| 10:27 ET |
Human Genome Sciences Completes Enrollment in Phase 2 Trials for Mirostipen
|
|
Sep 19, 01
|
| 12:45 ET |
Human Genome Sciences Announces Trial for Treatment Of Immunoglobulin-A Deficiency
|
|
Sep 10, 01
|
| 08:15 ET |
Human Genome Sciences Announces Webcasts of Investment Conference Presentations for September 2001
|
|
Sep 06, 01
|
| 11:06 ET |
Human Genome Sciences Receives Clinical Milestone Payment From Partner
|
|
Sep 04, 01
|
| 16:10 ET |
Human Genome Sciences Initiates New Clinical Trial For Treatment of Mucositis In Multiple Myeloma Patients
|
|
Aug 14, 01
|
| 08:15 ET |
Human Genome Sciences Names Ellen S. Baron, Ph.D. Senior Vice President, Business Development
|
|
Jul 26, 01
|
| 16:05 ET |
Human Genome Sciences Reports Financial Results for Second Quarter of 2001
|
|
Jul 25, 01
|
| 06:00 ET |
Human Genome Sciences and Medarex Announce Collaboration
|
|
Jul 18, 01
|
| 13:45 ET |
Human Genome Sciences' CEO Named to Board of Directors Of Biotechnology Industry Organization
|
|
Jul 11, 01
|
| 17:04 ET |
Human Genome Sciences' CEO Dr. William A. Haseltine Awarded Honorary Doctor of Science Degree by University of Portsmouth
|
|
Jul 02, 01
|
| 13:34 ET |
Human Genome Sciences Announces New Product and Partnership Possibilities
|
|
Jun 29, 01
|
| 08:00 ET |
Human Genome Sciences Will Sponsor Conference Call To Discuss Expiration of Exclusivity Aspects Of Human Gene Therapeutic Consortium
|
|
Jun 20, 01
|
| 16:01 ET |
Human Genome Sciences Breaks Ground for New R&D and Corporate Campus
|
|
Jun 12, 01
|
| 07:45 ET |
Steven C. Mayer Selected as CFO of the Year by Regional Technology Councils
|
|
Jun 05, 01
|
| 07:15 ET |
Human Genome Sciences' Albutropin IND Cleared by FDA
|
|
Jun 04, 01
|
| 08:30 ET |
Human Genome Sciences Announces Webcast of Presentations at Annual Analyst & Investor Meeting
|
|
May 24, 01
|
| 07:02 ET |
Human Genome Sciences Appoints Two New Members to Board of Directors
|
|
May 15, 01
|
| 07:01 ET |
Human Genome Sciences Completes Acquisition of Facility From Invitrogen
|
|
Apr 27, 01
|
| 06:55 ET |
Human Genome Sciences Reports Financial Results for First Quarter of 2001
|
|
Apr 25, 01
|
| 13:11 ET |
Human Genome Sciences Confirms Stock Sales By Chairman Were Completed Last Week
|
|
Apr 04, 01
|
| 07:45 ET |
Human Genome Sciences Will Sponsor Conference Call To Review Recent Activities
|
|
Mar 27, 01
|
| 00:05 ET |
Human Genome Sciences Announces Takeda Chemicals Has Selected Approximately 100 Targets for Drug Discovery Efforts
|
|
Mar 23, 01
|
| 00:05 ET |
Human Genome Sciences Begins Phase I Clinical Trial of Albuferon in Hepatitis C Patients
|
|
Mar 09, 01
|
| 09:44 ET |
Human Genome Sciences to Purchase New Research and Manufacturing Facility In Rockville, Maryland
|
|
Feb 27, 01
|
| 08:10 ET |
Human Genome Sciences Receives Orphan Drug Designation for BLyS Therapeutic Protein for Treatment of Common Variable Immunodeficiency
|
|
Feb 23, 01
|
| 17:44 ET |
Genomic Derived Drug for Cardiovascular Disease in Human Trials
|
|
Feb 21, 01
|
| 07:35 ET |
Human Genome Sciences Completes Construction of Antibody Manufacturing Facility
|
|
Feb 20, 01
|
| 16:30 ET |
Human Genome Sciences to Hold Conference Call to Review Activities of 2000
|
|
Feb 15, 01
|
| 08:05 ET |
Human Genome Sciences Reports Financial Results for Fourth Quarter And Full Year 2000
|
|
Jan 19, 01
|
| 07:59 ET |
Human Genome Sciences to Relocate Principia Unit to Rockville, Maryland
|
|
Dec 11, 00
|
| 08:15 ET |
Human Genome Sciences Added to Nasdaq-100 Index And Nasdaq-100 Index Tracking Stock
|
|
Dec 06, 00
|
| 16:16 ET |
Human Genome Sciences Bolsters Business and Corporate Development Team
|
|
| 16:15 ET |
Human Genome Sciences Expands Clinical Development Team
|
|
| 16:14 ET |
Human Genome Sciences Strengthens Management Team
|
|
Nov 07, 00
|
| 16:10 ET |
Human Genome Sciences Reports Third Quarter Financial Results
|
|
| 11:10 ET |
Human Genome Sciences Announces Third Quarter Conference Call
|
|
Oct 31, 00
|
| 08:15 ET |
Human Genome Sciences Announces Exercise of Over-Allotment Option
|
|
Oct 30, 00
|
| 01:00 ET |
High Levels of BLyS Implicated In Lupus and Rheumatoid Arthritis Patients
|
|
| 01:00 ET |
Human Genome Sciences and Cambridge Antibody Technology Commit To Exclusive Development of Anti-BLyS Antibodies
|
|
| 01:00 ET |
Human Genome Sciences and Dow Agree to Develop HGS' Radiolabeled B-Lymphocyte Stimulator
|
|
Oct 27, 00
|
| 08:15 ET |
Human Genome Sciences Prices Offering of $825 Million of Common Stock
|
|
Oct 19, 00
|
| 16:11 ET |
Human Genome Sciences Offering Shares of its Common Stock
|
|
| 04:45 ET |
Human Genome Sciences and Aventis Behring Collaborate To Jointly Develop and Commercialize Aventis Behring Plasma Protein Product
|
|
Oct 18, 00
|
| 17:43 ET |
Human Genome Sciences Submits IND for Albuferon(TM) to Treat Hepatitis C
|
|
Oct 16, 00
|
| 04:45 ET |
Human Genome Sciences and Smithkline Beecham Agree to Jointly Develop and Commercialize Repifermin, an HGS Product
|
|
Oct 09, 00
|
| 08:05 ET |
Schering-Plough Exercises Option to Develop and Commercialize One of Human Genome Sciences' Discoveries
|
|
Sep 18, 00
|
| 16:10 ET |
Human Genome Sciences' Board of Directors Approves Two-For-One Stock Split
|
|
Sep 13, 00
|
| 00:01 ET |
First Genomics-Based Drug Shows Clinical Activity in Human Trials
|
|
Sep 11, 00
|
| 00:30 ET |
Human Genome Sciences Enhances Biological Drug Discovery And Development Leadership Position by Acquiring Principia Pharmaceutical
|
|
Sep 06, 00
|
| 11:32 ET |
Human Genome Sciences Files
|
|
Jul 28, 00
|
| 12:00 ET |
Human Genome Sciences Reports Second Quarter Financial Results
|
|
Jul 21, 00
|
| 08:25 ET |
Human Genome Sciences Expects to Benefit From MedImmune/Smithkline Beecham Agreement Covering Streptococcus Pneumoniae Vaccine Development
|
|
Jul 12, 00
|
| 00:01 ET |
Transgene Selects Two Novel Cardiovascular Genes From Human Genome Sciences for Gene Therapy Development
|
|
Jun 23, 00
|
| 04:00 ET |
Human Genome Sciences to Initiate Human Clinical Trials of BLyS
|
|
May 26, 00
|
| 13:44 ET |
William A. Haseltine, Human Genome Sciences' CEO, Is Elected to Brookings Institution's Board of Trustees
|
|
May 23, 00
|
| 06:10 ET |
Human Genome Sciences to Initiate Third Phase II Clinical Trial Program of Repifermin; Ulcerative Colitis is Newest Indication
|
|
| 06:00 ET |
Favorable Phase II Results of Repifermin in Treatment of Chronic Venous Ulcers Reported by Human Genome Sciences
|
|
Apr 27, 00
|
| 05:55 ET |
Human Genome Sciences Reports First Quarter Financial Results
|
|
Apr 18, 00
|
| 14:54 ET |
Human Genome Sciences Added To American Stock Exchange's Biotechnology Index
|
|
Apr 13, 00
|
| 19:05 ET |
High Technology Council of Maryland Selects Human Genome Sciences As 'High Technology Firm of the Year'; Company Cited for Pioneering Efforts to Discover Genomics-Based Drugs
|
|
Mar 22, 00
|
| 14:02 ET |
Human Genome Sciences Completes Conversion Of 5% Convertible Subordinated Notes
|
|
Mar 21, 00
|
| 08:10 ET |
Human Genome Sciences to Develop Leadership in Peptide Drug Discovery Through Agreement With Dyax
|
|
Mar 13, 00
|
| 13:59 ET |
Preliminary Results Reported of Gene Therapy (VEGF-2) Trial In Coronary Artery Disease
|
|
Mar 10, 00
|
| 10:25 ET |
Human Genome Sciences Announces Completion of Offering
|
|
Mar 07, 00
|
| 10:45 ET |
Human Genome Sciences Raises $300 Million in Convertible Subordinated Debt Placement
|
|
Mar 06, 00
|
| 19:12 ET |
Human Genome Sciences Announces Proposed $300 Million Convertible Subordinated Debt Offering
|
|
Mar 02, 00
|
| 15:26 ET |
Human Genome Sciences Calls For Redemption of 5% Convertible Subordinated Notes Due 2006
|
|
| 08:02 ET |
Human Genome Sciences Announces Major New Initiative in Human Gene Mapping, Gene Polymorphism, and Gene Organization
|
|
Feb 29, 00
|
| 19:44 ET |
Human Genome Sciences Catapults to Leadership In Genomics-Based Human Antibody Product Development
|
|
Feb 28, 00
|
| 10:48 ET |
Human Genome Sciences Names Sally D. Bolmer, Ph.D., Vice President, Regulatory Affairs
|
|
Feb 25, 00
|
| 07:31 ET |
Human Genome Sciences, Vical and Vascular Genetics Enter Strategic Collaboration
|
|
Feb 16, 00
|
| 08:05 ET |
Human Genome Sciences Receives Patent On AIDS Virus Entry Point
|
|
Feb 10, 00
|
| 16:23 ET |
Human Genome Sciences Reports 1999 Financial Results
|
|
Feb 08, 00
|
| 13:36 ET |
Human Genome Sciences and Praecis Form Partnership In Small Molecule Drug Discovery
|
|
Feb 01, 00
|
| 13:21 ET |
Human Genome Sciences Announces Increase in Offering Size And Completion of Offering
|
|
Jan 31, 00
|
| 08:01 ET |
Advance in Asthma Research Announced
|
|
Jan 27, 00
|
| 09:58 ET |
Human Genome Sciences Raises $150 Million In Convertible Subordinated Debt Placement
|
|
Jan 24, 00
|
| 16:58 ET |
Human Genome Sciences Announces Proposed $150 Million Convertible Subordinated Debt Offering
|
|
Jan 19, 00
|
| 08:01 ET |
Human Genome Sciences Announces Phase II Human Clinical Trials of Repifermin For Cancer Treatment Related Mucositis
|
|
Jan 13, 00
|
| 08:02 ET |
Human Genome Sciences Announces Completion of Tender Offer For Convertible Notes
|
|
Jan 10, 00
|
| 08:29 ET |
Human Genome Sciences Announces Completion of Financing for Expansion Of Process Development and Manufacturing Facility - Adds Capacity to Manufacture Protein and Antibody Drugs in Mammalian Cells -
|
|
Jan 05, 00
|
| 14:30 ET |
Human Genome Sciences' Board of Directors Approves Two-For-One Stock Split
|
|
Dec 22, 99
|
| 16:42 ET |
Human Genome Sciences Announces Exercise of Option
|
|
Dec 15, 99
|
| 08:15 ET |
Human Genome Sciences Announces Four Promotions
|
|
Dec 14, 99
|
| 10:03 ET |
Human Genome Sciences Commences Tender Offer For 5 1/2% Convertible Subordinated Notes
|
|
Dec 09, 99
|
| 08:50 ET |
Human Genome Sciences Raises $150 Million in Convertible Subordinated Debt Placement
|
|
Dec 06, 99
|
| 08:15 ET |
Human Genome Sciences Announces Proposed $150 Million Convertible Subordinated Debt Offering and Exchange Offer for Existing Convertible Subordinated Debt
|
|
Dec 01, 99
|
| 06:59 ET |
Human Genome Sciences and Abgenix Enter a Broad Collaboration To Create Fully Human Antibody Therapeutics
|
|
Nov 01, 99
|
| 08:25 ET |
Human Genome Sciences Appoints David C. Stump, M.D., Senior Vice President, Drug Development
|
|
Oct 27, 99
|
| 16:16 ET |
Human Genome Sciences Calls Stockholder Meeting to Authorize Additional Shares
|
|
Oct 25, 99
|
| 08:15 ET |
Human Genome Sciences Reports Third Quarter Financial Results
|
|
Sep 10, 99
|
| 09:45 ET |
Human Genome Sciences Announces Change in Board of Directors
|
|
Aug 19, 99
|
| 08:05 ET |
Human Genome Sciences Appoints Vivian R. Albert, Ph.D. As Director of Molecular Biology
|
|
Aug 10, 99
|
| 08:05 ET |
Cambridge Antibody Technology and Human Genome Sciences Form Alliance In Therapeutic Antibodies
|
|
Aug 05, 99
|
| 13:00 ET |
New Anti-Angiogenic Proteins Discovered - Scientists at UCLA and Human Genome Sciences Report Discovery of Two Human Proteins, METH-1 and METH-2, That Inhibit Blood Vessel Formation
|
|
Jul 26, 99
|
| 08:25 ET |
Human Genome Sciences Reports Second Quarter Financial Results
|
|
Jul 23, 99
|
| 11:47 ET |
Human Genome Sciences Announces Exercise of Option
|
|
Jul 14, 99
|
| 07:30 ET |
Human Genome Sciences Announces Advance in Hodgkin's Lymphoma
|
|
Jul 08, 99
|
| 14:00 ET |
Human Genome Sciences Announces the Discovery of a Novel Immune Stimulant
|
|
Jun 22, 99
|
| 11:20 ET |
Human Genome Sciences Raises $100 Million in Convertible Subordinated Debt Placement
|
|
Jun 17, 99
|
| 12:47 ET |
Human Genome Sciences Collaborates in Second Gene Therapy Clinical Trials; Two Protocols Target Coronary Artery Disease
|
|
Apr 26, 99
|
| 11:11 ET |
Human Genome Sciences Reports First Quarter Financial Results
|
|
Apr 14, 99
|
| 07:01 ET |
Human Genome Sciences Opens Manufacturing and Process Development Plant New Facility Anchors HGS in Montgomery County, Maryland
|
|
Mar 29, 99
|
| 07:30 ET |
Vascular Genetics Inc. Announces First External Investment
|
|
| 07:29 ET |
Human Genome Sciences Announces Completion of Private Financing For Vascular Genetics Inc.
|
|
Feb 25, 99
|
| 07:05 ET |
Human Genome Sciences, Inc. Describes Three New Drugs in Human Clinical Trials And Unveils Functional Genomics and Patent Programs
|
|
Feb 11, 99
|
| 06:50 ET |
Human Genome Sciences Reports 1998 Financial Results
|
|
Feb 10, 99
|
| 07:30 ET |
Human Genome Sciences Initiates Phase II Human Clinical Trials Of KGF-2, a New Wound-Healing Drug
|
|
Dec 23, 98
|
| 07:29 ET |
Human Genome Sciences Announces Collaboration in Gene Therapy Clinical Studies
|
|
| 07:29 ET |
Vascular Genetics Initiates Gene Therapy Clinical Studies To Stimulate Growth Of Blood Vessels
|
|
| 07:29 ET |
Vascular Genetics Initiates Gene Therapy Clinical Studies To Stimulate Growth of Blood Vessels
|
|
Dec 10, 98
|
| 11:08 ET |
Human Genome Sciences Announces Personnel Promotions
|
|
Dec 03, 98
|
| 08:15 ET |
Human Genome Sciences Appoints Judith G. Giri, Ph.D., as Director of Cell Biology
|
|
Nov 18, 98
|
| 07:15 ET |
Human Genome Sciences Commences Phase II Clinical Studies of MPIF For Chemoprotection
|
|
Nov 16, 98
|
| 08:15 ET |
Human Genome Sciences Names Laura D'Andrea Tyson To Board Of Directors
|
|
Nov 13, 98
|
| 10:19 ET |
Human Genome Sciences Increases Ownership Stake in Vascular Genetics
|
|
Oct 29, 98
|
| 08:15 ET |
Human Genome Sciences Reports Third Quarter Financial Results
|
|
Sep 17, 98
|
| 07:20 ET |
Human Genome Sciences Confirms Number of Genes Published Under Patent Cooperation Treaty
|
|
Sep 15, 98
|
| 07:30 ET |
Human Genome Sciences Announces Resignation of Melvin D. Booth
|
|
Aug 25, 98
|
| 06:45 ET |
Human Genome Sciences Advances Clinical Testing of KGF-2 to Phase II Studies
|
|
Aug 05, 98
|
| 07:29 ET |
Human Genome Sciences Reports Second Quarter Financial Results
|
|
Jul 27, 98
|
| 08:45 ET |
Human Genome Sciences Appoints Daniel J. Odenheimer, Ph.D., As Director of Medical Affairs
|
|
Jun 04, 98
|
| 07:30 ET |
Human Genome Sciences and Affymetrix Announce Agreement to Develop Bacterial GeneChip(R) Probe Arrays
|
|
Jun 02, 98
|
| 06:45 ET |
Human Genome Sciences Announces Successful Safety Trial of Novel Cancer Drug; First Genomic Product to Enter Phase II Trials
|
|
May 21, 98
|
| 07:30 ET |
Human Genome Sciences Adopts Shareholder Rights Plan
|
|
May 18, 98
|
| 08:49 ET |
Human Genome Sciences Reports Twenty-Seventh U.S. Patent Issues
|
|
| 08:08 ET |
Human Genome Sciences Reports Twenty-Seventh U.S. Patent Issues
|
|
May 08, 98
|
| 09:40 ET |
Human Genome Sciences Reports First Quarter Financial Results
|
|
Apr 09, 98
|
| 10:41 ET |
Human Genome Sciences Announces Receipt of Additional TRANSGENE Shares; Stake of 10 Percent Maintained After Overallotment Option Exercise
|
|
Mar 02, 98
|
| 12:27 ET |
Human Genome Sciences and TRANSGENE Sign Gene Therapy Agreement
|
|
Feb 24, 98
|
| 12:28 ET |
Human Genome Sciences Reports 1997 Financial Results
|
|
Nov 10, 97
|
| 09:54 ET |
Human Genome Sciences Announces Participation in Formation of Vascular Genetics Inc.
|
|
Oct 21, 97
|
| 09:57 ET |
Human Genome Sciences Appoints Gardiner F.H. Smith as Director, Business Development
|
|
Oct 01, 97
|
| 12:52 ET |
Human Genome Sciences Places Cornerstone for New Manufacturing Plant In Montgomery County, Maryland
|
|
Sep 24, 97
|
| 09:58 ET |
Human Genome Sciences Appoints Arthur C. Louie, M.D., as VP-Medical Affairs
|
|
Aug 12, 97
|
| 12:52 ET |
Human Genome Sciences Reports Second Quarter Financial Results
|
|
Aug 05, 97
|
| 12:41 ET |
Human Genome Sciences Appoints Kathryn de Santis as Director, Corporate Communications and Investor Relations
|
|
Jul 25, 97
|
| 10:01 ET |
Human Genome Sciences and SmithKline Beecham Streamline Diagnostic Agreement
|
|
Jul 08, 97
|
| 10:03 ET |
Human Genome Sciences Achieves Milestone With Hoffmann-La Roche on Streptococcus Pneumoniae and Extends Collaboration to Include Enterococcus Faecalis
|
|
Jun 23, 97
|
| 10:27 ET |
HGS/TIGR Funding Relationship Reaches Early Conclusion
|
|
Jun 03, 97
|
| 10:28 ET |
Human Genome Sciences, Inc. Announces Site Location for Protein Production Facility
|
|